new glp 1 agonist for weight loss GLP-1 Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Study finds GLP-1 receptor agonists

They can also be used to prevent and treat endocrine disorders or metabolic diseases such as polycystic ovary syndrome (PCOS), obesity, and non-alcoholic fatty liver disease (NAFLD) (135)

Three semaglutide medications are currently approved by the FDA: Wegovy is approved for weight loss treatment, and can be prescribed to adults and children 12 and older with obesity, as well as some adults with overweight who also have weight-related health problems, such as high blood pressure

427,428,429 The compound NLY01 is particularly effective at attenuating the activity of proinflammatory microglia and preventing the transformation of astrocytes to a reactive phenotype

(2024) 47:S179218

Pharmacies must balance supply across patients using these drugs for diabetes and those using them for weight loss, often under conditions where availability, while improved compared to earlier shortages, is still uneven at the local level

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: A systematic review and meta-analysis